Patients with a therapeutic response in the anti-PD-L1 group had greater METTL1 expression, providing novel guidance for tumor treatment.277 Yang and colleagues constructed an m7G score model based on 19 m7G methylation-related genes using the TCGA database and the Gene Expression Omnibus (GEO) database. The gene discussed is METTL1; the disease is neoplasm.